refer to COA for component ratio) Strength: 70 mg total peptide content per vial Purity: 99% (HPLC verified, each component) Container: sealed glass vial (lyophilized powder) Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for all three component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
& Church, T
All tested compounds were found to cause eryptosis by externalizing PS and activating caspase-3
: : : Apex Biopharma Bioygen Core Labs X Jiabei Health Nanox Revange 1 17-19 : 22-24 : 27-30 : 15-21.10 : 3-5 : : - : 1-3 : : 1-3 : : : 1-2 : : : 0 - - - - - - - IGF1-LR3 - 0.1 mg (100 mcg) + TB-500 - 10 mg + BPC-157 - 10 mg for Injection, Apex Biopharma, 1 vial * 20 mg Apex Biopharma : ApBi-00015 100 12 902
Additional work on peptide solubilization reported in research databases shows that the use of preserved diluents with peptide compounds such as BPC-157, GHK-Cu, and CJC-1295 yields more consistent assay results than plain sterile water due to reduced microbial interference over multi-day study windows